Gofen & Glossberg LLC Ionis Pharmaceuticals Inc Transaction History

Gofen & Glossberg LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 12, 2019	SELL	$62.09 - $86.14 $189,374 - $262,727	-3,050 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$52.92 - $81.17 $161,406 - $247,568	3,050 New	3,050 $248,000
Q1 2018 Apr 11, 2018	SELL	$44.08 - $55.05 $223,044 - $278,553	-5,060 Closed	0 $0
Q4 2017 Jan 11, 2018	SELL	$50.3 - $64.39 $80,480 - $103,024	-1,600 Reduced 24.02%	5,060 $255,000
Q2 2017 Aug 16, 2017	BUY	N/A	6,660	6,660 $339,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

Stay updated on Gofen & Glossberg LLC with notifications on news.